Simultaneous effects of local dexfenfluramine application on extracellular glutamate and serotonin levels in rat frontal cortex: A reverse microdialysis study

Neuropharmacology

Volumn 38, Issue 4, 1999, Pages 513-523

  Rocher, Cyril ^a   Jacquot, Christian ^a   Gardier, Alain M ^a,b  

^a Inst Signalisation Innov T   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Dexfenfluramine; Frontocortical; Glutamate; High performance liquid chromatography; Reverse microdialysis; Serotonin

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; CHLORAMPHETAMINE; DEXFENFLURAMINE; FLUOXETINE; GLUTAMIC ACID; NEUROTRANSMITTER; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FRONTAL CORTEX; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION;

ANIMALS; BIOGENIC MONOAMINES; DEXFENFLURAMINE; EXTRACELLULAR SPACE; GLUTAMIC ACID; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TETRODOTOXIN;

EID: 0033026328     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00212-3     Document Type: Article

References (42)

1. Auerbach S.B., Minzenberg M.J., Wilkinson L.O. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499:1989;281-290.
2. 3H] imipramine. J. Pharmacol. Exp. Ther. 242:1987;364-371.
3. Benfield P., Heel R.C., Lewis S.P. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 32:1986;481-508.
4. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin R.A. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 34:1991;717-725.
5. Caccia S., Anelli M., Ferrarese A., Fracasso C., Garattini S. The role of D-norfenfluramine in the indole-depleting effect of D-fenfluramine in the rat. Eur. J. Pharmacol. 233:1993;71-77.
6. Carboni E., Di Chiara G. Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience. 32:1989;637-645.
7. Consolo S., Bertorelli R., Russi G., Zambelli M., Ladinsky H. Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors. J. Neurochem. 62:1994;2254-2261.
8. De Deurwaerdère P., Bonhomme N., Le Moal M., Spampinato U. D-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine upake sites. J. Neurochem. 65:1995;1100-1108.
9. Fuller R.W., Snoddy H.D., Robertson D.W. Mechanisms of effects of D-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol. Biochem. Behav. 30:1988;715-721.
10. Garattini S., Bizzi A., Caccia S., Mennini T., Samanin R. Progress in assessing the role of serotonin in the control of food intake. Clin. Neuropharmacol. 11(1):1988;S8-S32.
11. Gardier A.M., Kaakkola S., Erfurth A., Wurtman R.J. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Brain Res. 588:1992;67-74.
12. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. I: The disposition of 3H-norepinephrine, 3H-dopamine and 3H-dopa in various regions of the brain. J. Neurochem. 13:1966;655-669.
13. 3H] serotonin. Naunyn-Schmied Arch. Pharmacol. 345:1992;1-6.
14. Griffiths R., Dunlop J., Gorman A., Senior J., Grieve A. L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters. Biochem. Pharmacol. 47:1994;267-274.
15. Herrera-Marschitz M., You Z.B., Goiny M., Meana J.J., Silveira R., Godukhin O.V., Chen Y., Espinoza S., Pettersson E., Loidl C.F., Lubec G., Andersson K., Nylander I., Terenius L., Ungerstedt U. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J. Neurochem. 66:1996;1726-1735.
16. Invernizzi R., Kmieciak-kolada K., Samanin R. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine the rat brain? Br. J. Pharmacol. 75:1986;525-530.
17. Invernizzi R., Fracasso C., Caccia S., Di Clemente A., Garattini S., Samanin R. Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and D-fenfluramine in rats. Relation to brain drug concentrations. Eur. J. Pharmacol. 163:1989;77-83.
18. Johnson M.P., Nichols D.E. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Pharmacol. Biochem. Behav. 36:1990;105-109.
19. Laferrere B., Wurtman R.J. Effect of D-fenfluramine on serotonin release in brains of anesthetized rats. Brain Res. 504:1989;258-263.
20. Liu J., Moghaddam B. Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation. J. Pharmacol. Exp. Ther. 274:1995;1209-1215.
21. Malagié I., Trillat A.-C., Jacquot C., Gardier A.M. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur. J. Pharmacol. 286:1995;213-217.
22. Mamounas L.A., Mullen C.A., O'Hearn E., Molliver M.E. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314:1991;558-586.
23. Massieu L., Morales-Villagran A., Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64:1995;2262-2272.
24. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 60:1993;1650-1657.
25. Molliver D.C., Molliver M.E. Anatomic evidence for a neurotoxic effect of (±)fenfluramine upon serotonergic projections in the rat. Brain Res. 511:1990;165-168.
26. Obrenovitch T.P., Urenjak J., Zilkha E. Evidence disputing the link between seizure activity and high extracellular glutamate. J. Neurochem. 66:1996;2446-2454.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic, Sydney.
28. Raiteri M., Bonanno G., Vallebuona F. In vitro and in vivo effects of D-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J. Pharmacol. Exp. Ther. 273:1995;643-649.
29. Rawls S.M., McGinty J.F. L-trans-Pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade. J. Neurochem. 68:1997;1553-1563.
30. Richards R.P., Gordon P.H., Ings R.M.J., Campbell D.B., King L.J. The measurement of D-fenfluramine in plasma and urine with an application of the method to pharmacokinetic studies. Xenobiotica. 19:1989;547-554.
31. Rocher C., Bert L., Robert F., Trouvin J.-H., Renaud B., Jacquot C., Gardier A.M. Microdialysis monitoring of variations in extracellular levels of serotonin, GABA and excitatory amino acids in the frontal cortex of awake rats in response to a single peripheral or central administration of dexfenfluramine. Brain Res. 737:1996;221-230.
32. Rothstein J., Martin L., Levey A., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R. Localization of neuronal and glial glutamate transporters. Neuron. 13:1994;713-725.
33. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
34. Sabol K.E., Richards J.B., Seiden L.S. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585:1992;421-424.
35. Sanders-Bush E., Martin L.L. Osborne N.N. Storage and release of serotonin in biology of serotonergic transmission. 1982;63-94 Wiley, Chichester.
36. Sarkissian C.F., Wurtman R.J., Morse A.N., Gleason R. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex. Brain Res. 529:1990;294-301.
37. Schwartz D., Hernandez L., Hoebel B.G. Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res. 482:1989;261-270.
38. Series H.G., Cowen P.J., Sharp T. p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) and D-fenfluramine pretreatment attenuates D-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology. 116:1994;508-514.
39. Sonsalla P.K., Nicklas W.J., Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science. 243:1989;398-400.
40. Westerink B.H. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70:1995;103-124.
41. Wichems C.H., Hollingsworth C.K., Bennett B.A. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release. Brain Res. 695:1995;10-18.
42. Xue C.-J., Ng J.P., Li Y., Wolf M.E. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67:1996;352-363.